GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Shenqi Pharmaceutical Investment Management Co Ltd (SHSE:600613) » Definitions » Current Deferred Revenue

Shanghai Shenqi Pharmaceutical Investment Management Co (SHSE:600613) Current Deferred Revenue : ¥0 Mil (As of Sep. 2023)


View and export this data going back to 1992. Start your Free Trial

What is Shanghai Shenqi Pharmaceutical Investment Management Co Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Shanghai Shenqi Pharmaceutical Investment Management Co's current deferred revenue for the quarter that ended in Sep. 2023 was ¥0 Mil.

Shanghai Shenqi Pharmaceutical Investment Management Co Current Deferred Revenue Historical Data

The historical data trend for Shanghai Shenqi Pharmaceutical Investment Management Co's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Shenqi Pharmaceutical Investment Management Co Current Deferred Revenue Chart

Shanghai Shenqi Pharmaceutical Investment Management Co Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Shanghai Shenqi Pharmaceutical Investment Management Co Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Shanghai Shenqi Pharmaceutical Investment Management Co Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Shanghai Shenqi Pharmaceutical Investment Management Co's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Shenqi Pharmaceutical Investment Management Co (SHSE:600613) Business Description

Traded in Other Exchanges
Address
128 Weihai Road, Room 613, Changfa Building, Shanghai, CHN, 200003
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd is mainly engaged in pharmaceutical production and distribution in China.

Shanghai Shenqi Pharmaceutical Investment Management Co (SHSE:600613) Headlines

No Headlines